Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hainan General Sanyo Pharmaceutical is a leading Chinese pharmaceutical manufacturer focused on anti-infective medications, particularly cephalosporins and penicillins. Based in Haikou, the company operates as a key subsidiary of China Meheco Group, which is part of the state-owned China General Technology Group (Genertec). Its extensive product line includes high-end antibiotics such as Cefpirome Sulfate and Cefozopran Hydrochloride, alongside treatments for cardiovascular and gastrointestinal diseases. The company maintains advanced GMP-certified production lines for both oral and injectable formulations to serve the domestic and international markets. Hainan General Sanyo is recognized for its integration of research, production, and sales within the Chinese healthcare infrastructure.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hainan General Sanyo Pharmaceutical.